{"id":5685,"date":"2021-12-12T10:37:15","date_gmt":"2021-12-12T10:37:15","guid":{"rendered":"https:\/\/be.alfasigma.com\/?page_id=5685"},"modified":"2024-07-03T13:28:37","modified_gmt":"2024-07-03T13:28:37","slug":"mediacenter","status":"publish","type":"page","link":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/","title":{"rendered":"Mediacenter"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Media & Actualiteit \/ Mediacenter<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Mediacenter<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Persdossier<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Bedrijfspresentatie<\/a><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Onze medewerkers<\/a><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Alfasigma Belgium<\/a><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Fotobibliotheek<\/a><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Perscontacten<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

PRESS CONTACTS<\/strong><\/p>\n

Corporate Communication & Institutional Relations<\/strong><\/p>\n

Staff<\/strong><\/p>\n

CorporateCommunication@alfasigma.com<\/a><\/p>\n

+39.051.6489.511<\/a><\/p>


<\/p>\n

Press Office<\/strong><\/p>\n

pressoffice@alfasigma.com<\/a><\/p>\n

\n<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Lees verder\n<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Relatie HCP\/HCO<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ondersteuning voor zorgverleners (HCP\u2019s) en zorginstellingen (HCO\u2019s)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Geneesmiddelenbewaking (Farmacovigilantie)<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Het melden van bijwerkingen is belangrijk om pati\u00ebnten die geneesmiddelen gebruiken te beschermen en om een afweging tussen voordelen en risico\u2019s voor de bevolking te garanderen.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Maatschappelijk Verantwoord Ondernemen (MVO)<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tijdens de COVID-19-crisis hebben we hulpverleners een hart onder de riem gestoken en ondersteunden we hen door middel van tal van initiatieven wereldwijd.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Media & Actualiteit \/ Mediacenter Mediacenter Persdossier Bedrijfspresentatie Onze medewerkers Alfasigma Belgium Fotobibliotheek Perscontacten PRESS CONTACTS Corporate Communication & Institutional Relations Staff CorporateCommunication@alfasigma.com +39.051.6489.511 Press Office pressoffice@alfasigma.com Lees verder Relatie HCP\/HCO Ondersteuning voor zorgverleners (HCP\u2019s) en zorginstellingen (HCO\u2019s) Geneesmiddelenbewaking (Farmacovigilantie) Het melden van bijwerkingen is belangrijk om pati\u00ebnten die geneesmiddelen gebruiken te beschermen en om … Continued<\/a><\/p>\n","protected":false},"author":4,"featured_media":1931,"parent":797,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"views\/template-custom.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-5685","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAlfasigma BE - Mediacenter<\/title>\n<meta name=\"robots\" content=\"index,follow\" \/>\n<link rel=\"canonical\" href=\"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alfasigma BE - Mediacenter\" \/>\n<meta property=\"og:description\" content=\"Media & Actualiteit \/ Mediacenter Mediacenter Persdossier Bedrijfspresentatie Onze medewerkers Alfasigma Belgium Fotobibliotheek Perscontacten PRESS CONTACTS Corporate Communication & Institutional Relations Staff CorporateCommunication@alfasigma.com +39.051.6489.511 Press Office pressoffice@alfasigma.com Lees verder Relatie HCP\/HCO Ondersteuning voor zorgverleners (HCP\u2019s) en zorginstellingen (HCO\u2019s) Geneesmiddelenbewaking (Farmacovigilantie) Het melden van bijwerkingen is belangrijk om pati\u00ebnten die geneesmiddelen gebruiken te beschermen en om … Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/\" \/>\n<meta property=\"og:site_name\" content=\"Alfasigma BE\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-03T13:28:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/\",\"name\":\"Alfasigma BE - Mediacenter\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg\",\"datePublished\":\"2021-12-12T10:37:15+00:00\",\"dateModified\":\"2024-07-03T13:28:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/#primaryimage\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg\",\"contentUrl\":\"https:\\\/\\\/be.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/mediacenter\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nieuws & Media\",\"item\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/nieuws-media\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Mediacenter\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/\",\"name\":\"Alfasigma BE\",\"description\":\"Pharmaceuticals with passion\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/be.alfasigma.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alfasigma BE - Mediacenter","robots":{"index,follow":"index,follow"},"canonical":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/","og_locale":"nl_NL","og_type":"article","og_title":"Alfasigma BE - Mediacenter","og_description":"Media & Actualiteit \/ Mediacenter Mediacenter Persdossier Bedrijfspresentatie Onze medewerkers Alfasigma Belgium Fotobibliotheek Perscontacten PRESS CONTACTS Corporate Communication & Institutional Relations Staff CorporateCommunication@alfasigma.com +39.051.6489.511 Press Office pressoffice@alfasigma.com Lees verder Relatie HCP\/HCO Ondersteuning voor zorgverleners (HCP\u2019s) en zorginstellingen (HCO\u2019s) Geneesmiddelenbewaking (Farmacovigilantie) Het melden van bijwerkingen is belangrijk om pati\u00ebnten die geneesmiddelen gebruiken te beschermen en om … Continued","og_url":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/","og_site_name":"Alfasigma BE","article_modified_time":"2024-07-03T13:28:37+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/","url":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/","name":"Alfasigma BE - Mediacenter","isPartOf":{"@id":"https:\/\/be.alfasigma.com\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/#primaryimage"},"image":{"@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/#primaryimage"},"thumbnailUrl":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg","datePublished":"2021-12-12T10:37:15+00:00","dateModified":"2024-07-03T13:28:37+00:00","breadcrumb":{"@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/#primaryimage","url":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg","contentUrl":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/07\/POMEZIA_0725_FOTO_NICCOLO_BIDDAU-dida-2.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/mediacenter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/be.alfasigma.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Nieuws & Media","item":"https:\/\/be.alfasigma.com\/nl\/nieuws-media\/"},{"@type":"ListItem","position":3,"name":"Mediacenter"}]},{"@type":"WebSite","@id":"https:\/\/be.alfasigma.com\/nl\/#website","url":"https:\/\/be.alfasigma.com\/nl\/","name":"Alfasigma BE","description":"Pharmaceuticals with passion","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/be.alfasigma.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"}]}},"_links":{"self":[{"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/pages\/5685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/comments?post=5685"}],"version-history":[{"count":32,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/pages\/5685\/revisions"}],"predecessor-version":[{"id":6312,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/pages\/5685\/revisions\/6312"}],"up":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/pages\/797"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/media\/1931"}],"wp:attachment":[{"href":"https:\/\/be.alfasigma.com\/nl\/wp-json\/wp\/v2\/media?parent=5685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}